Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony nowotwór złośliwy piersi typu przewodowo-zrazikowy
- •Wiek co najmniej 18 lat
- •Dowolny podtyp receptorowy
- •Możliwość zrozumienia dokumentu zgody i gotowość jego podpisania
✗ Disqualifies
- •Rak piersi w stadium I-III
- •Brak cech nowotworu przewodowo-zrazikowego w wycinku biopsyjnym
- •Inny aktywny nowotwór złośliwy
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 2, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (4)
University of California, San Diego
San Diego, United States
University of California, San Francisco
San Francisco, United States
Abramson Cancer Center
Philadelphia, United States
MD Anderson Cancer Center
Houston, United States
Trial contact
Venezia Garza
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.